Teva Pharmaceutical Industries will start marketing its version of a brain tumor drug only if...
Mylan has settled patent litigation cases with Takeda concerning two diabetes drugs, the generic drug...
Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...
India’s Ranbaxy Labs will launch a generic version of a diabetes drug in two years,...
Caraco Pharmaceutical Labs has launched a generic version of a drug for treating colon and...
MORRISTOWN, N.J. Watson Pharmaceuticals and Takeda Pharmaceuticals North America have settled a patent litigation case...
An organization representing the generic drug industry is hoping that Congress gives the Food and...
The head of the Food and Drug Administration’s generic drug division is stepping down to...
An organization representing the generic drug industry is holding up a recent report by the...
The U.S. Court of Appeals for the District of Columbia has overturned a district court...
The Food and Drug Administration has approved the first generic version of a drug for...
With exception to those companies that are the first to win Food and Drug Administration...
The Food and Drug Administration has given E. Fougera & Co. approval for the first...
Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...
President Barack Obama’s proposed healthcare bill may have its supporters and detractors, but one group...
The Food and Drug Administration hopes to accelerate the review process for generic drugs, according...
Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for...
Teva Pharmaceutical Industries got a big boost in profits in 2009 compared with 2008, the...
On a lot of issues, the branded and generic drug industries agree about as readily...
A U.S. maker of generic injectable drugs has moved closer to acquiring the injectables business...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration to manufacture a generic...
Patent expiries on blockbuster branded drugs could mean huge profits for some retail pharmacy chains,...
Teva Pharmaceutical Industries has reached a settlement in a case alleging that governments had to...
Cephalon plans to buy a generic drug maker based in Switzerland for $590 million, the...
The Food and Drug Administration has approved a generic epilepsy drug made by Taro Pharmaceutical...